Proteomics joins major health study to target lung disease

Proteomics International announces it has joined forces with the Busselton Population Medical Research Institute (BPMRI) to target improved diagnosis and treatment of lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Media release


  • This field is for validation purposes and should be left unchanged.